The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Low rates of viral load testing among pregnant women highlight need to review care for pregnant women living with HIV.
Significant step as WHO recommends the dapivirine vaginal ring as a new HIV prevention tool following promising trial results
A study suggests vaginal bacteria may be playing an underestimated role in PrEP efficacy for women
Trial reports a 15% difference in high PrEP adherence among participants who received vouchers compared to those who didn’t – but this fell significantly after the vouchers stopped.
UChoose study is the first to assesses adolescent girls’ preferences for contraceptives that mirror PrEP products to establish what type of PrEP is most likely to work for them
Dutch study finds no evidence to suggest PrEP use increases mental health issues – and may actually help reduce sexual compulsivity and drug-misuse.
An evaluation of peer support clubs in settings with high HIV and gender-based violence prevalence finds increased self-esteem and self-efficacy among participants.
Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.
Modelling finds PrEP has the potential to avert between 3 and 8% of HIV infections in 13 African and Caribbean countries by 2030 if three key populations can access it
Research on PrEP safety for pregnant women and their babies finds no adverse effects – but knowledge gaps remain.
